Semaglutide to help smokers with diabetes quit
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This study tests if the diabetes drug semaglutide can help people with type 2 diabetes stop smoking more easily. Participants will get either semaglutide or a placebo to see if it improves quit rates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older with type 2 diabetes
- You live in Ontario, Canada
- You smoke at least 5 cigarettes a day and want to cut down or quit within the next 6 months
- Your blood sugar (HbA1c) is between 7% and 10% and stable over the last 3 to 6 months
- You have not used a GLP-1 drug (like Ozempic, Wegovy, or semaglutide) in the past 6 months
- You are not pregnant or breastfeeding, and don't have certain medical conditions like severe kidney disease, pancreatitis, or thyroid cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a medication used for type 2 diabetes (GLP-1 receptor agonists) can also reduce smoking in men with diabetes who smoke. If you qualify, you may receive this drug or a standard diabetes pill to see if it helps you smoke less.
This study tests a new medicine, NNC0662-0419, in people with type 2 diabetes. You must be willing to lose a lot of weight (more than a quarter of your current weight) as part of the study to see if the medicine helps lower blood sugar.
This trial tests if semaglutide, a diabetes and weight-loss medication, can improve psoriasis symptoms and reduce inflammation. It may be an option for people with both psoriasis and overweight or obesity, with or without diabetes.
This study tests whether the drug semaglutide (often used for weight loss) can help people who quit smoking avoid gaining weight. It's for people who are overweight or have weight-related health issues and want to stop smoking.
This study tests whether the medication semaglutide (similar to Ozempic/Wegovy) can help people who smoke and have obesity cut down on cigarettes, even if they aren't ready to quit. Participants will receive the drug and be monitored for changes in smoking habits and health.
This study tests if the diabetes drug semaglutide (also used for weight loss) can help reduce cocaine use in adults, including those living with HIV. It's free and lasts about 8 weeks.
Hear when a new Nicotine Addiction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.